AB
Alessandro Bovolenta
Member Of The Board And Chief Executive Officer at Qualifarma
View Alessandro's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Member Of The Board And Chief Executive Officer
Sep 2002 - Present · 22 years and 3 months
Field Trainer
Jan 1997 - Aug 2002 · 5 years and 7 months
Company Details
51-200 Employees
Since 2002, QualiFarma has been marketing drugs and OTC, medical devices, cosmetics food supplements for human use through its proprietary sales network. The company comprises expertise in various sectors – from pharmacy to chemistry, from finance to corporate consulting. QualiFarma decided to sell carefully selected products in pharmacies and drugstores. In order to ensure even more reliability, QualiFarma focuses on supporting and consulting its pharmacy clients. QualiFarma offers its deep expertise – pooled as strategic plan – to the pharmaceutical industry, focusing on the specific requirements related to selling innovative products for healthcare and improved quality of life. Product quality is the value our corporate philosophy is based on – always in view of ultimate safety.
Year Founded
2002
Social Media
LinkedinFacebook
Industry
Wellness and Fitness Services, Pharmaceutical preparations, generic, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Medicinal pastilles and lozenges, Pharmaceutical preparations NES, Pastiglie medicinali, Salute, prodotti medicinali e farmaceutici, Prodotti chimici, prodotti farmaceutici, materie plastiche, Prodotti farmaceutici diversi, non specificati altrove
HQ Location
via Dante Alighieri 39A Castell'Arquato, Piacenza 29014, IT
Keywords
marketing and distribution of OTCmarketing and distribution of cosmeticsmarketing and distribution of medical devices
Discover More About Cleveland Clinic

Find verified contacts of Alessandro Bovolenta in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.